Article
OCRL is a novel prognostic biomarker and its association with immunoregulation in breast cancer
2022-09-16
Abstract excerpt
<h4>Background: </h4> OCRL (Oculocerebrorenal syndrome of Lowe Protein) was originally well-known as the Lowe’s protein. However, the expression, significance and regulation mechanisms of OCRL in any cancers were not clear. <h4>Methods: </h4>: The bioinformation of breast cancer (BC) patients was required from TCGA (The Cancer Genome Atlas), and the expression was validated via IHC (immuno-histochemical analysis)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bfe43425-209f-5cf7-b27c-1d9382405be6
- DOI
- 10.21203/rs.3.rs-2032108/v1
